School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang Province, China.
State Key Laboratory and Key Laboratory of Vision Science, Ministry of Health and Zhejiang Provincial Key Laboratory of Ophthalmology and Optometry, Wenzhou, Zhejiang Province, China.
Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):1810-1821. doi: 10.1167/iovs.17-22689.
To identify the causative gene and investigate the corresponding mechanisms for an autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV) family.
Clinical examination and genetic analysis were performed in a Chinese ADNIV family. To dissect the molecular consequence, we used gene targeting to knock-in a patient's specific mutation in the mouse genome. Immunostaining and immunoprecipitation were harnessed to analyze the colocalization and interaction of CAPN5 with SLIT2 in photoreceptors. The purified SLIT2-N, SLIT2-C fragments, and the conditioned medium from 661W cells with the overexpression of CAPN5 were treated on ARPE-19 cells. The viability of ARPE-19 cells was determined by MTT assays. The activation of protein kinase A (PKA) was analyzed by immunofluorescence and Western blotting in 661W and ARPE-19 cells as well as in frozen retina tissue from wildtype (WT) and knock-in mice.
We identified a novel CAPN5 mutation (p.R289W) in a Chinese family and generated the knock-in CAPN5R289W mouse. This mutation caused abnormal proliferative RPE in both humans and mice. CAPN5 directly cleaved WT SLIT2 in vitro, but not the mutant SLIT2 (p.R1113I). CAPN5 interacted with the SLIT2 in mouse retinal photoreceptors (661W cells) and increased cleavage and secretion of the SLIT2 fragments (SLIT2-N and SLIT2-C). Conditioned medium induced higher levels of secreted SLIT2 fragments, which promoted PKA activation and promoted proliferation of ARPE-19 cells.
The novel CAPN5 mutation (p.R289W) is responsible for the present ADNIV family. The mutant CAPN5 stimulated secretion and cleavage of SLIT2 fragments that may act as a bystander to regulate abnormal RPE cell proliferation for ADNIV.
鉴定常染色体显性新生血管性炎症性玻璃体视网膜病变(ADNIV)家系的致病基因,并探讨相应的机制。
对一个中国 ADNIV 家系进行临床检查和遗传分析。为了剖析分子后果,我们使用基因靶向技术将患者特定的突变敲入到小鼠基因组中。通过免疫染色和免疫沉淀来分析 CAPN5 与光感受器中的 SLIT2 的共定位和相互作用。用 CAPN5 过表达的 661W 细胞的条件培养基处理纯化的 SLIT2-N、SLIT2-C 片段和 SLIT2-N、SLIT2-C 片段。通过 MTT 测定法测定 ARPE-19 细胞的活力。通过免疫荧光和 Western blot 在 661W 和 ARPE-19 细胞以及野生型(WT)和敲入小鼠的冷冻视网膜组织中分析蛋白激酶 A(PKA)的激活。
我们在中国一个家族中发现了一种新的 CAPN5 突变(p.R289W),并生成了 CAPN5R289W 敲入小鼠。该突变导致人类和小鼠的 RPE 异常增生。CAPN5 在体外直接切割 WT SLIT2,但不切割突变型 SLIT2(p.R1113I)。CAPN5 在小鼠视网膜光感受器(661W 细胞)中与 SLIT2 相互作用,并增加 SLIT2 片段(SLIT2-N 和 SLIT2-C)的切割和分泌。条件培养基诱导更高水平的分泌 SLIT2 片段,促进 PKA 激活并促进 ARPE-19 细胞的增殖。
新的 CAPN5 突变(p.R289W)是导致目前 ADNIV 家系的原因。突变型 CAPN5 刺激 SLIT2 片段的分泌和切割,这些片段可能作为旁观者调节 ADNIV 中异常的 RPE 细胞增殖。